Chris Garabedian
Portfolio Manager, Venture (PXV Fund)
Boston, Massachusetts, United States
9 investmentsChris Garabedian is a Portfolio Manager, Venture (PXV Fund) based in Boston, Massachusetts, United States. Chris Garabedian has backed 9 companies, including Tellus Therapeutics, Nephraegis Therapeutics and CereVasc. Investment focus areas include Health Care, Autoimmune Diseases and Biotech.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (9)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Tellus Therapeutics | — | — | — | — |
| 2 | Nephraegis Therapeutics | — | — | — | — |
| 3 | CereVasc | — | — | — | — |
| 4 | Landos Biopharma | — | — | — | — |
| 5 | Juno Diagnostics | — | — | — | — |
| 6 | Peroxitech Therapeutics | — | — | — | — |
| 7 | Zucara Therapeutics | — | — | — | — |
| 8 | AsclepiX Therapeutics | — | — | — | — |
| 9 | Shifa Biomedical | — | — | — | — |
Showing 1–9 of 9
Access Full Contact Information
Get Chris Garabedian's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.